Bristol Myers Squibb BMY
NYSE BMY
$67.01 +1.54 (+2.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bristol Myers Squibb Co (BMY) Land & Improvements (2025 - 2026)

Bristol Myers Squibb (BMY) posted quarterly Land & Improvements of $157.0 million for Q2 2026, little changed quarter-over-quarter from $157.0 million in Q1 2026.

Bristol Myers Squibb Co (BMY) Land & Improvements (2025 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Land & Improvements for 2 consecutive years, with $157.0 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Land & Improvements changed N/A year-over-year to $157.0 million; the TTM figure through Jun 2026 stood at $157.0 million (changed N/A YoY), while the FY2025 annual figure was $157.0 million, changed N/A from the prior year.
  • Land & Improvements was little changed at $157.0 million in Q2 2026 per BMY's latest filing, from $157.0 million in the prior quarter.
  • Across five years, Land & Improvements topped out at $157.0 million in Q4 2025 and bottomed at $157.0 million in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 157.00 Mn
Mar 31, 2026 157.00 Mn
Dec 31, 2025 157.00 Mn